Evidence map›Paper›PMID 26974273›Full record

ArticleBone marrow transplantation2016

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study.

F V Michelis, E G Atenafu, S Couban, J Frazer, S Shivakumar, D E Hogge, C L Toze, W Rajkhan, H J Kim, A Daly and 13 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

F V MichelisAllogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
E G AtenafuDepartment of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
S CoubanQueen Elizaberth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada.
J FrazerQueen Elizaberth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada.
S ShivakumarQueen Elizaberth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada.
D E HoggeLeukemia/BMT Program of British Columbia, Vancouver General Hospital, BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada.
C L TozeLeukemia/BMT Program of British Columbia, Vancouver General Hospital, BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada.
W RajkhanLeukemia/BMT Program of British Columbia, Vancouver General Hospital, BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada.
H J KimDepartment of Hematology, Catholic BMT Center, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
A DalyDepartments of Medicine and Oncology, Foothills Hospital and Tom Baker Cancer Centre, Calgary, AB, Canada.
J SlabyDepartments of Medicine and Oncology, Foothills Hospital and Tom Baker Cancer Centre, Calgary, AB, Canada.
J FinkeDepartment of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
T KissDepartment of Haematology-Oncology, Stem Cell Transplant Program, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada.
C BredesonThe Ottawa Hospital Blood & Marrow Transplant Program, Ottawa, ON, Canada.
M SabloffThe Ottawa Hospital Blood & Marrow Transplant Program, Ottawa, ON, Canada.
D SheppardThe Ottawa Hospital Blood & Marrow Transplant Program, Ottawa, ON, Canada.
M BakkarThe Ottawa Hospital Blood & Marrow Transplant Program, Ottawa, ON, Canada.
M BruneSection of Hematology and Coagulation, Sahlgrenska University Hospital, Sahlgrenska Academy, Göteborg, Sweden.
D A WallSection of Haematology/Oncology, Department of Internal Medicine, Faculty of Medicine, University of Manitoba, CancerCare Manitoba, Winnipeg, MB, Canada.
K PaulsonSection of Haematology/Oncology, Department of Internal Medicine, Faculty of Medicine, University of Manitoba, CancerCare Manitoba, Winnipeg, MB, Canada.
G PopradiDivision of Hematology, McGill University Health Centre, Montreal, QC, Canada.
I WalkerDepartment of Hematology, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada.
H A MessnerAllogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedComorbidityHematopoietic Stem Cell TransplantationHumansLeukemia, Myeloid, AcuteMiddle AgedRemission InductionRetrospective StudiesTreatment OutcomeYoung Adult

Identifiers

PMID26974273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.